Acquiring Company
Revvity
Acquired Company
Human Cell Design
Description
Revvity, Inc. has announced a definitive agreement to acquire Human Cell Design, a biotechnology firm based in France. This acquisition aims to enhance Revvity's Life Sciences portfolio by integrating HCD’s human pancreatic beta cell models. The move supports advancements in drug discovery, screening, and preclinical research.
Don't miss Revvity's next move
Get an email the moment Revvity makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Human Cell Design?
Human Cell Design was acquired by Revvity, based in Waltham. The deal was reported on September 9, 2026. Revvity, Inc. is a global enterprise specializing in strategic and operational initiatives, scientific innovation, and complex global development, all with a deep commitment to sustainability and cybersecurity. Revvity is publicly traded (RVTY) and operates in Biotechnology.
When did Revvity acquire Human Cell Design?
Revvity's acquisition of Human Cell Design was reported on September 9, 2026. Revvity, Inc. has announced a definitive agreement to acquire Human Cell Design, a biotechnology firm based in France. This acquisition aims to enhance Revvity's Life Sciences portfolio by integrating HCD’s human pancreatic beta cell models. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Human Cell Design do?
Human Cell Design is a biotechnology company that specializes in creating human cell models for research. The company's solutions are particularly focused on preclinical research for diabetes, obesity, and various metabolic diseases. It is privately held, operating in Biotechnology, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.